🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, randomized, open label, 2 way crossover drug drug intera...
Status
Completed
Location
Brussels Clinical Research Unit
Start Date
2019-04-18
Trial ID
NCT03916406
Treatments Being Tested
This is a double-blind, placebo-controlled study in adults with non-alcohol...
Status
Completed
Location
Horizon Clinical Research Associates, PLLC
Start Date
2019-07-18
Trial ID
NCT03969719
Treatments Being Tested
Hereditary fructose intolerance (HFI) is a rare inborn error of metabolism....
Status
Completed
Location
Maastricht University Medical centre
Start Date
2023-06-15
Trial ID
NCT06089265
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2016-10
Trial ID
NCT02974374
Treatments Being Tested
Part A will investigate the safety, tolerability, PK and PD of PF-06835919 ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2017-01
Trial ID
NCT03031119
Treatments Being Tested
IN THIS PHASE 2A, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, 3 ARM, PARA...
Status
Completed
Location
National Research Institute
Start Date
2017-09-27
Trial ID
NCT03256526
Treatments Being Tested
The study is proposed to characterize the effect of varying degrees of hepa...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2020-01-21
Trial ID
NCT04193436
Treatments Being Tested
This is a Phase 1 study to evaluate the safety, tolerability, and pharmacok...
Status
Completed
Location
Brussels Clinical Research Unit
Start Date
2020-11-24
Trial ID
NCT04427917
Treatments Being Tested
Fructose is a big contributor to the development of non-alcoholic fatty liv...
Status
Completed
Location
Maastricht University Medical centre
Start Date
2022-10-01
Trial ID
NCT05463575
Treatments Being Tested